Poland· PL-100213891
Dolenio
A glucosamine product containing glucosaminum, registered in Poland by Blue Bio Pharmaceuticals Limited. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Glucosamine is registered in 14 of 19 countries.
Countries holding a registration under ATC M01AX05 (glucosamine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Glucosamine · ATC M01AX05
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- United Kingdom
Price per daily dose
What a daily dose of glucosamine costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Glucosamine · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- ES Spain$0.23
The record
At a glance
URPL (Poland)- Active substance
- Glucosaminum
- Manufacturer
- Blue Bio Pharmaceuticals Limited
- Country
- Poland (PL)
- ATC code
- M01AX05
- ATC class
- Glucosamine
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 9
- gtin05909990825875
- gtin05909990825882
- gtin05909990825899
- gtin05909990825905
- gtin05909990825936
- gtin05909990825943
- gtin05909990825950
- gtin05909990721382
- gtin05909990721375
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for glucosamine.
Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Glucosamine · interactions on record
2 records
- 2 moderate
Most severe, free to view
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Glucosamine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBAYFLEXBlue Bio Pharmaceuticals Limited, Dublin
- FranceDOLENIO 1178 mg, comprimé pelliculéBLUE BIO PHARMACEUTICALS (IRLANDE)
- IcelandDolenioBlue Bio Pharmaceuticals Limited
- NetherlandsDolenio 1178 mg, filmomhulde tabletBlue Bio Pharmaceuticals Limited
- United KingdomAlateris 625mg tabletsLexon (UK) Ltd
- SpainACENAM 1250 mg COMPRIMIDOS EFERVESCENTESEspecialidades Farmaceuticas Centrum S.A.
- SwedenArtroxan 625 mg Kapsel, hårdEvolan Pharma AB
- IrelandArthrimel 1500mg Film Coated TabletsPhoenix Labs
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Cyprus · Donarthril
- Czechia · Artaxin, Flexove
- Germany · Glucosamin Doppelherzpharma
- Spain · Acenam, Duartron
- Finland · Glucosamin Orion
- France · Flexea, Osaflexan
- United Kingdom (Northern Ireland) · Glucosamine Medley Pharma, Yointy
- Greece · Donarot, Energorot
- Hungary · Cartilamin, Glukozamin Pharma Nord
- Ireland · Arthrimel, Dona
- Iceland · Glucomed
- Norway · Glucosamin Orifarm, Samin
- Portugal · Biartril, Glucomed
- Sweden · Artroxan, Glucomed
- Slovakia · Glucomed
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/02b363f7-9da5-44bb-8907-9e4cae560189 GET /v1/drugs/02b363f7-9da5-44bb-8907-9e4cae560189?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "1178 mg",
"packaging": "05909990825875 ¦ Rp ¦ 2214\n4 tabl.\n05909990825882 ¦ Rp ¦ Skasowane ¦ 2415\n10 tabl.\n05909990825899 ¦ Rp ¦ 14269\n20 tabl.\n05909990825905 ¦ Rp ¦ 14434\n30 tabl. w blistrach\n05909990825936 ¦ Rp ¦ Skasowane ¦ 14590\n45 tabl.\n05909990825943 ¦ Rp ¦ 16880\n60 tabl.\n05909990825950 ¦ Rp ¦ 19923\n90 tabl.\n05909990721375 ¦ Rp ¦ 52361\n30 tabl. w butelce\n05909990721382 ¦ Rp ¦ Skasowane ¦ 52362\n90 tabl.",
"substance": "Glucosaminum 1178 mg/ tabletkę (w postaci glukozaminy siarczanu z sodu chlorkiem- 1884,6 mg)",
"common_name": "Glucosaminum",
"pl_product_id": "100213891",
"pozwolenie_nr": "15773",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about glucosamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.